A scientist conducting proteomics research and metabolomics analysis in a state-of-the-art laboratory, working to ensure the safety and efficacy of pharmaceutical products




The pharmaceutical industry is a highly regulated sector, with a primary focus on ensuring the safety, quality, and efficacy of medicinal products. One critical aspect of this process is the identification and quantification of extractables and leachables (E&L) in drug products and their packaging. These studies are essential for minimizing potential health risks and maintaining compliance with regulatory guidelines. Synergy Bioscience, a leader in the field, offers comprehensive solutions for E&L analysis that help manufacturers guarantee product safety and meet stringent regulatory requirements.


What are Extractable and Leachable Studies?

Extractable studies involve identifying and quantifying the chemical compounds that can be extracted from the materials used in pharmaceutical products, such as drug containers, closures, and other components under specific conditions. These compounds, referred to as extractables, can migrate into the drug product over time or under specific conditions, potentially affecting the safety, efficacy, and stability of the drug.

Leachable studies, on the other hand, are conducted on the finished drug product to identify and quantify any compounds that have migrated from the packaging materials or other components into the drug product under normal storage and use conditions. These compounds, called leachables, may pose risks to patient safety or compromise the drug’s performance.


The Importance of E&L Studies in the Pharmaceutical Industry

Patient Safety: E&L studies are crucial for ensuring patient safety, as leachables can have toxic, mutagenic, or even carcinogenic effects. Identifying and quantifying these compounds help manufacturers implement appropriate measures to minimize exposure and potential health risks.


Drug Efficacy: Leachables can interact with drug substances, altering their chemical structure or degrading them, compromising the drug’s intended therapeutic effect. E&L studies help identify potential interactions to ensure the drug remains efficacious throughout its shelf life.


Regulatory Compliance: E&L studies are required to meet the guidelines set forth by regulatory agencies such as the FDA, EMA, and ICH. These agencies mandate that pharmaceutical manufacturers demonstrate an understanding of the potential impact of extractables and leachables on the drug product’s safety, efficacy, and stability.


Synergy Bioscience: A Trusted CRO in E&L Analysis

Synergy Bioscience has established itself as a trusted partner for pharmaceutical manufacturers seeking comprehensive E&L solutions. With a team of experienced scientists and state-of-the-art analytical equipment, Synergy Bioscience provides accurate, reliable, and timely results that help manufacturers ensure product safety and maintain regulatory compliance.


Expertise: Synergy Bioscience’s team has extensive experience in conducting E&L studies across a wide range of pharmaceutical products, including small molecules, biologics, and combination products. Their expertise enables them to design and execute robust study protocols tailored to each product’s unique requirements.


Advanced Analytical Techniques: Synergy Bioscience employs cutting-edge analytical techniques such as gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), and inductively coupled plasma-mass spectrometry (ICP-MS) to accurately identify and quantify trace levels of extractables and leachables in complex matrices.


Regulatory Support: Synergy Bioscience provides valuable support in navigating the complex regulatory landscape, ensuring that E&L studies comply with the latest guidelines and requirements. This support includes assistance with risk assessments, study design, data interpretation, and documentation.



Extractable and leachable studies play a vital role in ensuring the safety, efficacy, and quality of pharmaceutical products. Synergy Bioscience, with its extensive expertise and cutting-edge analytical capabilities, has emerged as a go-to partner for pharmaceutical manufacturers seeking reliable and comprehensive E&L analysis solutions. By offering tailored study designs, state-of-the-art techniques, and valuable regulatory support, Synergy Bioscience enables manufacturers to navigate the challenges of E&L studies and ensure the highest standards of safety and quality for their products.

In an ever-evolving regulatory environment, partnering with a trusted expert like Synergy Bioscience can provide peace of mind for manufacturers and ultimately protect the well-being of patients who rely on these medications. As the pharmaceutical industry continues to advance and innovate, Synergy Bioscience remains committed to delivering unparalleled E&L analysis services that meet the needs of manufacturers and contribute to the overall safety and effectiveness of life-saving medicines.


To discuss how Synergy Bioscience can help you, please contact us